ProStrakan is engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major global markets.

Our goal is to build a successfully international specialty pharmaceutical company based on a self-sustaining business model.

At its most simple, that means bringing products to market – either from our development portfolio or by in-licensing – to be sold by our own sales forces in major markets.

The revenues from increasing product sales will, in turn, provide for greater investment in development and geographic expansion.